Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000350564

Medchemexpress LLC Bemnifosbuvir | 1998705-64-8 | 99.0% | 581.53 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY13795850MG

Encompass_Preferred

Bemnifosbuvir (AT-511) is a potent and orally active inhibitor of HCV viral replication. It is highly effective in controlling SARS-CoV-2 (COVID-19) infection in vitro with an EC90 of 0.47 μM. Bemnifosbuvir exhibits pangenotypic antiviral activity.

  • Highly effective in controlling SARS-CoV-2 (COVID-19) infection in vitro
  • Exhibits pangenotypic antiviral activity
  • Inhibits HCV genotype 1a (EC50: 12.8 nM)
  • Inhibits HCV GT1b (EC50: 12.5 nM)
  • Inhibits HCV GT2a (EC50: 9.2 nM)
  • Inhibits HCV GT3a (EC50: 10.3 nM)
  • Inhibits HCV GT4a (EC50: 14.7 nM)
  • Inhibits HCV GT5a (EC50: 28.5 nM)
  • Preferentially delivers high levels of AT-9010 to the liver in vivo

Catalog No. 50-003-50564


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.